Pierre Bedard

@PRB51

PhD (Chemistry) MBA Biotechnology Investor Data Economy There are no perfect drugs nor perfect deals

Montreal Canada
Vrijeme pridruživanja: svibanj 2009.

Tweetovi

Blokirali ste korisnika/cu @PRB51

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @PRB51

  1. Prikvačeni tweet
    3. sij 2015.

    New year eve show 11y old racers synchro skiing. Mine: #3 with Orange head + Green hand+ White feet

    Poništi
  2. 4. velj

    With all due respect to M This is * in silico * work No laboratory experimental data No rats Let’s be careful here

    Poništi
  3. proslijedio/la je Tweet
    4. velj
    Poništi
  4. proslijedio/la je Tweet
    3. velj

    While has had to paste warning signs about papers not being peer reviewed, what this example shows is that, in the rush to publish, even peer reviewed journals will let the occasional unreliable piece of data slip by.

    Prikaži ovu nit
    Poništi
  5. 1. velj
    Poništi
  6. proslijedio/la je Tweet
    1. velj

    Lamenting the preprint in about "uncanny similarity" between coronavirus and HIV? "Although one might assume that journals would hold a strong hand when it comes to ridding themselves of bogus papers, that’s not always the case."

    Poništi
  7. proslijedio/la je Tweet

    S&P Performance through prior, viral outbreaks, via SunTrust:

    Poništi
  8. proslijedio/la je Tweet
    29. sij
    Poništi
  9. proslijedio/la je Tweet
    29. sij

    A step forward for somatic gene-editing therapy to treat cardiac and skeletal muscle disease

    Poništi
  10. proslijedio/la je Tweet
    25. sij
    Poništi
  11. proslijedio/la je Tweet
    23. sij

    Helpful summary of what's up with the Wuhan coronavirus in . Any bets on whether bats are going to be to blame again?

    Poništi
  12. 23. sij

    Added to position this am

    Poništi
  13. Poništi
  14. proslijedio/la je Tweet
    22. sij

    A meningococcal group B vaccine was introduced in the U.K. as part of the infant vaccination program. Investigators from Public Health England assessed the effect of this vaccination on the incidence of meningococcal group B disease.

    Poništi
  15. 22. sij

    So, seem that confirmatory trial will not be seen any time soon (ever?) If the company was confident about the expected results the trial would have been completed (or nearly so) by now.

    Poništi
  16. proslijedio/la je Tweet
    21. sij

    CMS just released a treasure trove of prescription drug spending data. Here’s what we found.

    Poništi
  17. proslijedio/la je Tweet

    Provocative insight from excellent Bernstein Research: Medicaid is highly incentivized to stick with older branded biologics because of heavy rebates on incumbents that can make them virtually free, and has little to no incentive to adopt biosimilars—frustrating low cost entrants

    Poništi
  18. 21. sij

    Genetics always an interesting surprise this may be of general interest

    Poništi
  19. proslijedio/la je Tweet
    20. sij

    Comparing healthcare costs around the world via

    Poništi
  20. proslijedio/la je Tweet

    . recently increased Medicare's new technology add-on payment (NTAP) for cases with high costs involving eligible new technologies. This removes disincentives to patient access and reduces uncertainty for innovators.

    Prikaži ovu nit
    Poništi
  21. proslijedio/la je Tweet
    15. sij
    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·